BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2979265)

  • 21. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
    Howden CW; Forrest JA; Reid JL
    Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of omeprazole on insulin induced gastric secretion in man.
    Utley RJ; Wright R; Beastall GH; Carter DC
    Scott Med J; 1985 Apr; 30(2):96-100. PubMed ID: 3892679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment.
    Lind T; Cederberg C; Forssell H; Olausson M; Olbe L
    Scand J Gastroenterol; 1988 Dec; 23(10):1259-66. PubMed ID: 3249924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients.
    Lind T; Cederberg C; Olausson M; Olbe L
    Gastroenterology; 1990 Dec; 99(6):1593-8. PubMed ID: 2227275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.
    Thomson AB; Keelan M; Lastiwka R; Appelman-Eszczuk S; Zuk L; Drozdowski L; Prentice A; Sinclair P
    Dig Dis Sci; 2003 Oct; 48(10):2045-56. PubMed ID: 14627354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated high oral doses of omeprazole do not affect intrinsic factor secretion: proof of a selective mode of action.
    Festen HP; Tuynman HA; Den Hollander W; Meuwissen SG
    Aliment Pharmacol Ther; 1989 Aug; 3(4):375-9. PubMed ID: 2518851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily.
    Thompson JN; Barr JA; Collier N; Spencer J; Bush A; Cope L; Gribble RJ; Baron JH
    Gut; 1985 Oct; 26(10):1018-24. PubMed ID: 3932137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of omeprazole on plasma zinc levels after oral zinc administration.
    Ozutemiz AO; Aydin HH; Isler M; Celik HA; Batur Y
    Indian J Gastroenterol; 2002; 21(6):216-8. PubMed ID: 12546170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man.
    Ten Kate RW; Tuynman HA; Festen HP; Pals G; Meuwissen SG
    Eur J Clin Pharmacol; 1988; 35(2):173-6. PubMed ID: 3142776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of once-daily intravenous and oral omeprazole on pentagastrin-stimulated acid secretion in duodenal ulcer patients.
    Cederberg C; Lind T; Röhss K; Olbe L
    Digestion; 1992; 53(3-4):171-8. PubMed ID: 1291405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Omeprazole and liver functions].
    Sauvet P; Schouler L
    Rev Med Interne; 1992; 13(5):359-63. PubMed ID: 1344831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of oral omeprazole in llamas.
    Poulsen KP; Smith GW; Davis JL; Papich MG
    J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omeprazole: pharmacokinetics and metabolism in man.
    Cederberg C; Andersson T; Skånberg I
    Scand J Gastroenterol Suppl; 1989; 166():33-40; discussion 41-2. PubMed ID: 2690330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of 7 years' daily oral administration of omeprazole to beagle dogs.
    Säfholm C; Havu N; Forssell H; Sundell G; Mattsson H
    Digestion; 1994; 55(3):139-47. PubMed ID: 8174826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole.
    Hussein Z; Granneman GR; Mukherjee D; Samara E; Hogan DL; Koss MA; Isenberg JI
    Br J Clin Pharmacol; 1993 Nov; 36(5):391-8. PubMed ID: 12959285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
    Miner PB; Fort JG; Zhang Y
    Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of oral doses of lansoprazole and omeprazole on gastric pH.
    Tolman KG; Sanders SW; Buchi KN; Karol MD; Jennings DE; Ringham GL
    J Clin Gastroenterol; 1997 Mar; 24(2):65-70. PubMed ID: 9077718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral pharmacokinetics of omeprazole.
    Howden CW; Meredith PA; Forrest JA; Reid JL
    Eur J Clin Pharmacol; 1984; 26(5):641-3. PubMed ID: 6468483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion.
    Biemond I; Crobach LF; Jansen JB; Lamers CB
    Eur J Clin Pharmacol; 1989; 37(4):345-9. PubMed ID: 2598968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.